RAPT Therapeutics, Inc. Current Assets
RAPT Therapeutics, Inc. had Current Assets of $161.04 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-06
- 2025-09-30: Assets, Current $161.04M.
- 2025-06-30: Assets, Current $172.86M.
- 2025-03-31: Assets, Current $183.20M.
- 2024-12-31: Assets, Current $235.24M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $161.04M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $172.86M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $183.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $235.24M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $102.60M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $120.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $148.36M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $161.78M 10-K · filed 2025-03-06 |
| 2023-09-30 | $187.14M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $207.42M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $234.59M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $252.69M 10-K · filed 2024-03-07 |
| 2022-09-30 | $197.89M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $209.93M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $175.66M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $192.97M 10-K · filed 2023-03-14 |
| 2021-09-30 | $214.50M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $227.96M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $102.61M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $115.60M 10-K · filed 2022-03-10 |
| 2020-09-30 | $125.51M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $136.08M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $146.89M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $80.51M 10-K · filed 2021-03-11 |
| 2019-09-30 | $51.22M 10-Q · filed 2019-12-11 |
| 2018-12-31 | $65.06M 10-K · filed 2020-03-30 |